1 year return (CAGR)
329.28%
Fusion Pharmaceuticals Inc Exchange (NASDAQ, USD)
FUSN
-
+0.03 (+0.14%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
38.28%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.83B
Price/Sales
51.38
Ent value
1.89B
Price/Book
7.58
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
18.34%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 21.55 |
| Daily high | 21.59 |
| Daily low | 21.45 |
| Daily Volume | 6.08M |
| 1y analyst estimate | 21.14 |
| Beta | -0.69 |
| EPS (TTM) | -1.24 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FUSN | S&P500 | |
| Current price drop from All-time high | -0.09% | -0.67% |
| Highest price drop | -88.86% | -56.47% |
| Date of highest drop | 7 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -57.48% | -10.68% |
| Avg time to new high | 76 days | 12 days |
| Max time to new high | 936 days | 1805 days |
News
No items found